Filter
1314
Filtered Results: 1314
Text search:
molecular
testing
Featured
Recommendations
172
New Publications
266
Language
Document type
No document type
600
Guidelines
282
Studies & Reports
243
Manuals
77
Strategic & Response Plan
58
Fact sheets
27
Training Material
15
Situation Updates
7
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
81
Global
46
Western and Central Europe
44
Latin America and the Carribbean
34
Kenya
28
Africa
24
Eastern Europe
24
South Africa
23
Tanzania
22
Ethiopia
20
Brazil
18
Germany
16
Nigeria
14
West and Central Africa
13
East and Southern Africa
13
Sierra Leone
12
Malawi
12
Rwanda
11
South–East Asia Region
11
Uganda
11
Russia
11
Philippines
10
Zambia
10
Colombia
9
Peru
9
Zimbabwe
9
Indonesia
9
Liberia
9
Nepal
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
USA
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Senegal
4
Burkina Faso
4
Middle East and North Africa
4
Ecuador
4
Pakistan
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
North America
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
406
Clinical Guidelines
169
Pharmacy & Technologies
56
Public Health
45
Key Resources
27
Women & Child Health
19
Capacity Building
4
Toolboxes
TB
270
COVID-19
173
AMR
107
NTDs
89
HIV
86
Rapid Response
66
Ebola & Marburg
37
Mental Health
34
Malaria
28
Planetary Health
27
Pharmacy
27
Zika
20
Refugee
16
NCDs
15
Polio
12
Specific Hazards
11
Health Financing Toolbox
8
Caregiver
6
Cholera
5
Conflict
5
Natural Hazards
4
Disability
4
Global Health Education
2
Social Ethics
1
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
Towards a world free of tuberculosis
August 2020.
In December 2018, the President launched the UHC pilot covering four strategically selected counties-Isiolo, Kisumu, Machakos and Nyeri. It isplanned that by the year 2022, all persons in Kenya will be able to use the essential services they need for their health...
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
Updated July 3, 2020
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The "Regional Action Plan 2017–2030: Towards a Malaria-Free South-East Asia Region" by the World Health Organization (WHO) outlines a strategic framework to eliminate malaria in the 11 countries of the WHO South-East Asia Region by 2030. It focuses on reducing transmission, particularly of Plasmod...
Scientific Brief, 17 June 2020
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
To deliver on the Global Fund Strategy milestones
for 2028 and ensure we keep the SDG 3 target
within reach, we need to raise US$18 billion to
fund the Global Fund’s next three-year grant cycle.
The purpose of this guide is to provide updated clinical guidance on TB/HIV, with an emphasis on diagnostic aspects—including new techniques—as well as current treatment, while maintaining a public health approach. By compiling and consolidating the latest World Health Organization recommendatio...
Epidemiologisches Bulletin3 | 202121. Januar 2021 (online vorab)
Informe
Bogotá, 13-14 de abril del 2015
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Accessed: 03.09.2019
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
